Literature DB >> 20567620

Adjuvant interferon alfa for melanoma.

Kenneth S Wilson, Andrew Attwell.   

Abstract

Entities:  

Keywords:  Melanoma; adjuvant; interferon

Year:  2010        PMID： 20567620      PMCID： PMC2880905          DOI： 10.3747/co.v17i3.511

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  4 in total

1.  High-dose interferon versus GM2 vaccine in high-risk malignant melanoma.

Authors:  K Wilson
Journal:  J Clin Oncol       Date:  2001-12-01       Impact factor: 44.544

2.  Adjuvant interferon in high-risk melanoma: end of the era?

Authors:  Filip Janku; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

3.  High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

Authors:  J M Kirkwood; J G Ibrahim; V K Sondak; J Richards; L E Flaherty; M S Ernstoff; T J Smith; U Rao; M Steele; R H Blum
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

4.  Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.

Authors:  Dimitrios Pectasides; Urania Dafni; Dimitrios Bafaloukos; Dimosthenis Skarlos; Aristidis Polyzos; Dimosthenis Tsoutsos; Haralambos Kalofonos; George Fountzilas; Petros Panagiotou; George Kokkalis; Othon Papadopoulos; Ourania Castana; Stefanos Papadopoulos; Elias Stavrinidis; Georgia Vourli; John Ioannovich; Helen Gogas
Journal:  J Clin Oncol       Date:  2009-01-12       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.